Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Auteurs » - entrée « A. H. V. Schapira »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
A. H. Schapira < A. H. V. Schapira < A. H. Zwinderman  Facettes :

List of bibliographic references indexed by A. H. V. Schapira

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000370 (2011) A. H. V. Schapira [Royaume-Uni]Challenges to the development of disease‐modifying therapies in Parkinson’s disease
000A48 (2009) A. H. V. Schapira [Royaume-Uni] ; M. Emre [Turquie] ; P. Jenner [Royaume-Uni] ; Werner Poewe [Autriche]Levodopa in the treatment of Parkinson’s disease
000C96 (2008) A. H. V. Schapira [Royaume-Uni]Progress in neuroprotection in Parkinson’s disease
000E57 (2008) L. Bet [Italie] ; S. R. Bareggi [Italie] ; F. Pacei [Italie] ; G. Bondiolotti [Italie] ; G. Meola [Italie] ; A. H. V. Schapira [Royaume-Uni]Bimodal administration of entacapone in Parkinson’s disease patients improves motor control
001494 (2005) C. A. Davie ; A. H. V. Schapira [Royaume-Uni]First-line Treatment in Parkinson’s Disease
001906 (2002) A. H. V. SchapiraDopamine agonists and neuroprotection in Parkinson's disease
001A44 (2001) M. Orth ; A. H. V. Schapira [Royaume-Uni]Mitochondria and degenerative disorders
002595 (1992) V. M. Mann [Royaume-Uni] ; J. M. Cooper [Royaume-Uni] ; D. Krige [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; A. H. V. Schapira [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
002624 (1992) Jenner [Royaume-Uni] ; D. T. Dexter [Royaume-Uni] ; J. Sian [Royaume-Uni] ; A. H. V. Schapira [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Parkinson’s disease
3levodopa
3neuroprotection
2dopamine agonist
2mitochondria
1Alzheimer disease
1Friedreich ataxia
1Huntington disease
1Parkinson disease
1Parkinson's disease
1Wilson disease
1aetiology
1amyotrophic lateral sclerosis
1apoptosis
1autophagy
1catechol‐O‐methyl transferase
1catechol‐O‐methyl transferase inhibitor
1continuous stimulation
1dopamine
1dopamine agonists
1entacapone
1fluctuations
1genes
1hereditary spastic paraparesis
1monoamine oxidase B inhibitor
1monoamine oxidase inhibitors
1neurodegenerative disorders
1pathogenesis
1propargylamines
1wearing off

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "A. H. V. Schapira" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "A. H. V. Schapira" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    A. H. V. Schapira
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024